Financhill
Sell
25

SCPH Quote, Financials, Valuation and Earnings

Last price:
$2.27
Seasonality move :
-3.25%
Day range:
$2.47 - $2.64
52-week range:
$1.94 - $5.65
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.04x
P/B ratio:
9.36x
Volume:
81.9K
Avg. volume:
397.8K
1-year change:
-46.78%
Market cap:
$124.7M
Revenue:
$36.3M
EPS (TTM):
-$1.90

Earnings Data

Next earnings date for SCPH
May 14
2025
Most recent earnings per share
-$0.35
Beat by $0.04
(Mar 19/2025)
Consensus Estimate
-$0.39
(Mar 19/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SCPH Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 $15.8M -- -- -$0.27 --
05/14/2025 Q1 $11.6M -- -- -$0.29 --
03/19/2025 Q4 $12.2M $12.2M -$0.35 -$0.39 $0.04
11/13/2024 Q3 $10.8M $10M -$0.75 -$0.30 -$0.45
08/14/2024 Q2 $8M $8.1M -$0.44 -$0.41 -$0.03
05/14/2024 Q1 $6M $6.1M -$0.36 -$0.43 $0.07
03/13/2024 Q4 $5.8M $6.1M -$0.35 -$0.41 $0.06
11/08/2023 Q3 -- -- -$0.41 -$0.37 -$0.04
08/10/2023 Q2 -- -- -$0.36 -$0.38 $0.02
05/10/2023 Q1 -- -- -$0.30 -$0.38 $0.08
03/22/2023 Q4 -- -- -$0.30 -$0.39 $0.09
11/09/2022 Q3 -- -- -$0.37 -$0.41 $0.04
08/09/2022 Q2 -- -- -$0.35 -$0.32 -$0.03
05/16/2022 Q1 -- -- -$0.28 -$0.29 $0.01
03/22/2022 Q4 -- -- -$0.27 -$0.34 $0.07
11/09/2021 Q3 -- -- -$0.24 -$0.32 $0.08
08/11/2021 Q2 -- -- -$0.26 -$0.30 $0.04
05/12/2021 Q1 -- -- -$0.26 -$0.30 $0.04
03/23/2021 Q4 -- -- -$0.28 -$0.37 $0.09
11/16/2020 Q3 -- -- -$0.33 -$0.37 $0.04
08/13/2020 Q2 -- -- -$0.36 -$0.42 $0.06
05/12/2020 Q1 -- -- -$0.35 -$0.54 $0.19
03/24/2020 Q4 -- -- -$0.58 -$0.52 -$0.06
11/12/2019 Q3 -- -- -$0.33 -$0.42 $0.09
08/07/2019 Q2 -- -- -$0.39 -$0.49 $0.10
05/08/2019 Q1 -- -- -$0.47 -$0.49 $0.02
03/21/2019 Q4 -- -- -$0.27 -$0.45 $0.18
11/13/2018 Q3 -- -- -$0.31 -$0.54 $0.23
08/14/2018 Q2 -- -- -$0.53 -$0.57 $0.03
05/07/2018 Q1 -- -- -$0.47 -$0.50 $0.03
03/20/2018 Q4 -- -- -$0.46 -$0.51 $0.05

scPharmaceuticals Earnings Questions

  • How Much did scPharmaceuticals Generate in Revenue Last Quarter?

    scPharmaceuticals reported $12.2M worth of top line sales in its most recent quarter.

  • Did scPharmaceuticals Beat Earnings Last Quarter?

    scPharmaceuticals announced earnings per share of -$0.35 which represents a beat of analyst forecast a -$0.39 per share.

  • Is scPharmaceuticals Profitable?

    scPharmaceuticals reported $8.2M that represents $0.15 per share over the last quarter.

  • What is the Analyst Consensus for scPharmaceuticals EPS Next Year?

    scPharmaceuticals's earnings are forecast to decrease from -$1.91 per share to -$1.78 per share next year representing a decrease of -51.96%.

  • When is scPharmaceuticals's Earnings Date?

    scPharmaceuticals's next earnings date is May 14, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Broadcom Stock a Millionaire Maker?
Is Broadcom Stock a Millionaire Maker?

Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…

Is Berkshire The Best Stock to Buy in a Bad Market?
Is Berkshire The Best Stock to Buy in a Bad Market?

Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…

Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?

The big picture trends in e‑commerce sales are clearly in…

Stock Ideas

Buy
71
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
63
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Buy
60
RGC alert for May 6

Regencell Bioscience Holdings [RGC] is up 73.72% over the past day.

Buy
63
SKX alert for May 6

Skechers USA [SKX] is down 0.07% over the past day.

Sell
20
PTCT alert for May 6

PTC Therapeutics [PTCT] is down 11% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock